These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29935904)

  • 1. PD-1 immunobiology in autoimmune hepatitis and hepatocellular carcinoma.
    Curran CS; Sharon E
    Semin Oncol; 2017 Dec; 44(6):428-432. PubMed ID: 29935904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of autoimmune hepatitis is mediated by IL-18-producing dendritic cells and hepatic CXCL9 expression in mice.
    Ikeda A; Aoki N; Kido M; Iwamoto S; Nishiura H; Maruoka R; Chiba T; Watanabe N
    Hepatology; 2014 Jul; 60(1):224-36. PubMed ID: 24700550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses.
    Chew V; Lai L; Pan L; Lim CJ; Li J; Ong R; Chua C; Leong JY; Lim KH; Toh HC; Lee SY; Chan CY; Goh BKP; Chung A; Chow PKH; Albani S
    Proc Natl Acad Sci U S A; 2017 Jul; 114(29):E5900-E5909. PubMed ID: 28674001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of blood lymphocyte subsets and natural killer cells in schistosomal liver cirrhosis and hepatocellular carcinoma.
    Attallah AM; Tabll AA; El-Sadany M; Ibrahim TA; El-Dosoky I
    Clin Exp Med; 2003 Nov; 3(3):181-5. PubMed ID: 14648234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppressive drugs affect interferon (IFN)-γ and programmed cell death 1 (PD-1) kinetics in patients with newly diagnosed autoimmune hepatitis.
    Grant CR; Holder BS; Liberal R; Heneghan MA; Ma Y; Mieli-Vergani G; Vergani D; Longhi MS
    Clin Exp Immunol; 2017 Jul; 189(1):71-82. PubMed ID: 28257599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible involvement of chemokine C-C receptor 7
    Kimura N; Yamagiwa S; Sugano T; Setsu T; Tominaga K; Kamimura H; Takamura M; Terai S
    J Gastroenterol Hepatol; 2018 Jan; 33(1):298-306. PubMed ID: 28591933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging concepts in autoimmune encephalomyelitis beyond the CD4/T(H)1 paradigm.
    Batoulis H; Addicks K; Kuerten S
    Ann Anat; 2010 Aug; 192(4):179-93. PubMed ID: 20692821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune Regulation by T Regulatory Cells in Hepatitis B Virus-Related Inflammation and Cancer.
    Trehanpati N; Vyas AK
    Scand J Immunol; 2017 Mar; 85(3):175-181. PubMed ID: 28109025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of tumor-associated regulatory T cell deletion and PD-1/PD-L1 blockade: A promising immunotherapy for hepatocellular carcinoma?
    Yang HY; Sun LJ; Mao YL
    Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):93-94. PubMed ID: 29576280
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.
    Kakita N; Kanto T; Itose I; Kuroda S; Inoue M; Matsubara T; Higashitani K; Miyazaki M; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    Int J Cancer; 2012 Dec; 131(11):2573-83. PubMed ID: 22419479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell mediators of autoimmune hepatitis and their therapeutic implications.
    Montano-Loza AJ; Czaja AJ
    Dig Dis Sci; 2015 Jun; 60(6):1528-42. PubMed ID: 25487192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific CD8(+) T cell response immunotherapy for hepatocellular carcinoma and viral hepatitis.
    Moreno-Cubero E; Larrubia JR
    World J Gastroenterol; 2016 Jul; 22(28):6469-83. PubMed ID: 27605882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Histone Deacetylase 6 Reprograms Interleukin-17-Producing Helper T Cell Pathogenicity and Facilitates Immunotherapies for Hepatocellular Carcinoma.
    Qiu W; Wang B; Gao Y; Tian Y; Tian M; Chen Y; Xu L; Yao TP; Li P; Yang P
    Hepatology; 2020 Jun; 71(6):1967-1987. PubMed ID: 31539182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of the Regulatory T lymphocytes in hepatitis C fibrosis progression].
    Delhem N; Cottrez F; Carpentier A; Miroux C; Moralès O; François V; Groux H; Auriault C; Pancré V
    Bull Cancer; 2008 Nov; 95(11):1029-38. PubMed ID: 19036674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking Tim-3 or/and PD-1 reverses dysfunction of tumor-infiltrating lymphocytes in HBV-related hepatocellular carcinoma.
    Liu F; Zeng G; Zhou S; He X; Sun N; Zhu X; Hu A
    Bull Cancer; 2018 May; 105(5):493-501. PubMed ID: 29576222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contradictory intrahepatic immune responses activated in high-load hepatitis C virus livers compared with low-load livers.
    Ishibashi M; Yamaguchi H; Hirotani Y; Sakurada A; Endo T; Sugitani M; Takayama T; Makishima M; Esumi M
    Arch Virol; 2018 Apr; 163(4):855-865. PubMed ID: 29248968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Analysis of Immunoactivation by Nanosecond Pulsed Electric Fields and PD-1 Blockade in Murine Hepatocellular Carcinoma.
    Yimingjiang M; Tuergan T; Chen X; Wen H; Shao Y; Zhang R; Aihaiti K; Xue J; Aji T; Zhang W
    Anal Cell Pathol (Amst); 2020; 2020():9582731. PubMed ID: 32802733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous expression of Th1 cytokines and IL-4 confers severe characteristics to type I autoimmune hepatitis in children.
    Cherñavsky AC; Paladino N; Rubio AE; De Biasio MB; Periolo N; Cuarterolo M; Goñi J; Galoppo C; Cañero-Velasco MC; Muñoz AE; Fainboim H; Fainboim L
    Hum Immunol; 2004 Jul; 65(7):683-91. PubMed ID: 15301856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma with hepatitis B and C virus infection.
    Kakumu S; Ito S; Ishikawa T; Mita Y; Tagaya T; Fukuzawa Y; Yoshioka K
    J Gastroenterol Hepatol; 2000 Apr; 15(4):431-6. PubMed ID: 10824889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NK cells are the crucial antitumor mediators when STAT3-mediated immunosuppression is blocked in hepatocellular carcinoma.
    Sui Q; Zhang J; Sun X; Zhang C; Han Q; Tian Z
    J Immunol; 2014 Aug; 193(4):2016-23. PubMed ID: 25015826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.